Despite new treatments, lung cancer continues to prove a deadly disease.  

Only 15 percent of patients survive.

But researchers at the Peggy and Charles Stephenson Cancer Center hope to change that with a new approach that utilizes special targeted nanoparticles.

JavaScript is disabled! To display this content, you need a JavaScript capable browser. Adobe Flash Player not installed or older than 9.0.115!

In this Video Rajagopal Ramesh, Ph.D Peggy and Charles Stephenson Cancer Center, OUHSC

Peggy and Charles Stephenson Cancer Center researchers say the ultimate goal for this sort of work is to be able to develop highly-personalized treatments for each cancer patient to improve outcomes and survival.

The research was funded in part by grants from the National Cancer Institute and The Joans Legacy: United against Lung Cancer.